APREA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

At the special meeting of stockholders (the "Special Meeting") of Aprea Therapeutics, Inc. (the "Company") held on November 16, 2022, the following proposals were submitted to the stockholders of the Company. For more information about the foregoing proposals, please refer to the Company's proxy statement filed with the Securities and Exchange Commission on October 26, 2022.

Proposal 1: Stockholders approved the amendments to the Company's Certificate of

             Incorporation, to effect a reverse stock split at a ratio of 1-for-3
             and 1-for-20, inclusive, with the exact ratio to be set within that
             range at the discretion of the Company's Board of Directors before
             February 28, 2023 without further approval or authorization of our
             stockholders and with our Board of Directors able to elect to abandon
             such proposed amendment and not effect the Reverse Stock Split
             authorized by stockholders, in its sole discretion.



Votes For    Votes Against   Abstentions   Broker Non-Votes
36,030,837     2,418,669       450,037            -

Proposal 2: Stockholders approved the adjournment of the Special Meeting to a

             later date or dates, if necessary or appropriate, to solicit
             additional proxies if there are insufficient votes to adopt the
             Reverse Stock Split Proposal.



Votes For    Votes Against   Abstentions   Broker Non-Votes
36,441,099     1,892,580       565,864            -

© Edgar Online, source Glimpses